Prediction of response of collagen-induced arthritis rats to methotrexate: An ¹H-NMR-based urine metabolomic analysis

Abstract

Over one half the patients with rheumatoid arthritis (RA) are being treated with methotrexate (MTX). Although well proven, the efficacy of MTX varies in individual patients. This study examined the metabolic biomarkers that can be used to predict the therapeutic effect of MTX by using metabolomic analysis. Rats were immunized with collagen to rapidly cause collagen-induced arthritis (CIA) and then treated with 0.1 mg/kg MTX for 4 weeks. The clinical signs and the histopathological features of CIA were observed to evaluate the therapeutic effects. Urine samples of CIA rats were collected, and analyzed by using 600 M ¹H-nuclear magnetic resonance (¹H-NMR) for spectral binning after the therapy. The urine spectra were divided into spectral bins, and 20 endogenous metabolites were assigned by Chenomx Suite. Multivariate analyses were performed to identify the spectral pattern of endogenous metabolites related to MTX therapy. The results showed that the clustering of the spectra of the urine samples from the responsive rats (n=20) was different from that from the non-responsive rats (n=11). Multivariate analysis showed difference in metabolic profiles between the responsive and non-responsive rats by using partial least squares-discrimination analysis (PLS-DA) (R²=0.812, Q²=0.604). In targeted profiling, 13 endogenous metabolites (uric acid, taurine, histidine, methionine, glycine, etc.) were selected as putative biomarkers for predicting therapeutic response to MTX. It was suggested that ¹H-NMR-based metabolomic analysis can be used to predict the therapeutic effect of MTX, and several metabolites were found to be related to the therapeutic effects of MTX.

Keywords

¹H- nuclear magnetic resonance / metabolomics / methotrexate / collagen-induced arthritis

References

[1] VallbrachtI., RieberJ., OppermannM., et al.. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis, 2004, 63(9): 1079-1084

[2] WardM.M.. Rheumatoid arthritis: Guidelines for the management of RA: breadth versus depth. Nat Rev Rheumatol, 2009, 5(6): 302-303

[3] RanganathanP., McLeodH.L.. Methotrexate pharmacoge netics: the first step toward individualized therapy in rheumatoid arthritis. Arthritis Rheum, 2006, 54(5): 1366-1377

[4] GrimJ., ChládekJ., MartÍnkováJ.. Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases. Clin Pharmacokinet, 2003, 42(2): 139-151

[5] InoueS., HashiguchiM., TakagiK., et al.. Preliminary study to identify the predictive factors for the response to methotrexate therapy in patients with rheumatoid arthritis. Yakugaku Zasshi, 2009, 129(7): 843-849

[6] DervieuxT., FurstD., LeinD.O., et al.. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis. Arthritis Rheum, 2004, 50(9): 2766-2774

[7] KumagaiK., HiyamaK., OyamaT., et al.. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis. Int J Mol Med, 2003, 11(5): 593-600

[8] TakatoriR., TakahashiK.A., TokunagaD., et al.. ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients. Clin Exp Rheumatol, 2006, 24(5): 546-554

[9] RudwaleitM., YinZ., SiegertS., et al.. Response to methotrexate in early rheumatoid arthritis is associated with a decrease of T cell derived tumour necrosis factor increase of interleukin 10, and predicted by the initial concentration of interleukin 4. Ann Rheum Dis, 2000, 59(4): 311-314

[10] BaraldiE., CarraroS., GiordanoG., et al.. Metabolomics: moving towards personalized medicine. Ital J Pediatr, 2009, 35(1): 30

[11] NicholsonJ.K., LindonJ.C.. Systems biology: Metabonomics. Nature, 2008, 455(7216): 1054-106

[12] UmS.Y., ChungM.W., KimK.B., et al.. Pattern recognition analysis for the prediction of adverse effects by nonsteroidal anti-inflammatory drugs using ¹H NMR-based metabolomics in rats. Anal Chem, 2009, 81(12): 4734-4741

[13] LenzE.M., WilsonI.D.. Analytical strategies in metabonomics. J Proteome Res, 2007, 6(2): 443-6458

[14] SalveminiD., MazzonE., DugoL., et al.. Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic. Arthritis Rheum, 2001, 44(12): 2909-2921

[15] SmithR.J., SlyL.M.. Type II collagen-induced arthritis in the diabetic-resistant biobreeding rat: inflammatory and histopathological features of joint pathology and effects of antiinflammatory and antirheumatic drugs on this chronic arthritic process. J Pharmacol Exp Ther, 1996, 277(3): 1801-1813

[16] BrahnE., BanquerigoM.L., FiresteinG., et al.. Collagen induced arthritis: reversal by mercaptoethylguanidine, a novel antiinflammatory agent with a combined mechanism of action. J Rheumatol, 1998, 25(9): 1785-1793

[17] OnoY., InoueM., MizukamiH., et al.. Suppressive effect of Kanzo-bushi-to, a Kampo medicine, on collagen-induced arthritis. Biol Pharm Bull, 2004, 27(9): 1406-1413

[18] WeiL., LiaoP., WuH., et al.. Toxicological effects of cinnabar in rats by NMR-based metabolic profiling of urine and serum. Toxicol Appl Pharmaco, 2008, 227(3): 417-429

[19] JansenJ.J., HoefslootH.C., BoelensH.M., et al.. Analysis of longitudinal metabolomics data. Bioinformatics, 2004, 20(15): 2438-2446

[20] ChevallierS., BertrandD., KohlerA., et al.. Application of PLS-DA in multivariate image analysis. J Chemometr, 2006, 20(5): 221-229

[21] BarkerM., RayensW.. Partial least squares for discrimination. J Chemometrics, 2003, 17(3): 166-173

[22] KimS.H., YangS.O., KimH.S., et al.. ¹H-nuclear magnetic resonance spectroscopy-based metabolic assessment in a rat model of obesity induced by a high-fat diet. Anal Bioanal Chem, 2009, 395(4): 1117-1124

[23] WeljieA.M., DowlatabadiR., MillerB.J., et al.. An inflammatory arthritis-associated metabolite biomarker pattern revealed by ¹H NMR spectroscopy. J Proteome Res, 2007, 6(9): 3456-3464

[24] JureckaA.. Inborn errors of purine and pyrimidine metabolism. J Inherit Metab Dis, 2009, 32(2): 247-263

[25] ReesW.D., WilsonF.A., MaloneyC.A.. Sulfur amino acid metabolism in pregnancy: the impact of methionine in the maternal diet. J Nutr, 2006, 136(6Suppl): 1701-1705

[26] FolateS.J.. Vitamin B12 and vitamin B6 and one carbon metabolism. J Nutr Health Aging, 2002, 6(1): 39-42

[27] LenzE.M., BrightJ., WilsonI.D., et al.. A ¹H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. J Pharm Biomed Anal, 2003, 33(5): 1103-1115